Cathy specializes in intellectual property relating to pharmaceuticals and general chemistry matters, including small molecule drugs, salt forms, solid forms, and chemical processes. She also has worked on various litigation matters involving pharmaceutical and chemical products.

Cathy works with clients to protect their innovations and procure intellectual property through intellectual property strategies that are integrated with each client’s business goals. She works with public and private companies of all sizes and stages of development, including venture funded start-ups, venture capital partnerships, and entities that invest in, or evaluate, pharmaceutical and life science companies and technologies.

Cathy approaches each client and each matter with the drive and focus required to master the project at hand. She works to integrate the intellectual property with the practical business issues faced by the client, including scientific, financial, regulatory, and competitive issues. Her client projects are varied and include designing and managing worldwide patent estates on drug candidates, evaluating competitive landscapes to determine patentability and freedom to operate, procuring IP strategy for early stage start-up companies, performing IP due diligence for investors, and advising on license agreements, collaborations, and regulatory issues.

Education and Prior Experience

  • Harvard Law School, J.D.
  • Yale University M.S., Chemistry
  • Indiana University, B.S., Chemistry, with honors
  • Medicinal chemist in drug discovery at Vertex Pharmaceuticals, Abbott Laboratories, and Parke-Davis (now Pfizer); she is an inventor on five issued U.S. Patents

Admissions, Memberships, and Acknowledgements

  • Admitted to practice law in Massachusetts
  • Registered to practice before the U.S. Patent and Trademark Office